Maputo, Mozambique, 17 Nov – The first phase of the anti-retroviral medication factory in Mozambique is due to be in operation by the end of the year, according to a report in newspaper Notícias, citing a guarantee given by the Brazilian Ministry for Development, Industry and Foreign Trade.
The installation of the anti-retroviral medication is part of a cooperation strategy between Brazil and Mozambique and is being implemented by the Osvaldo Cruz Foundation (Fiocruz), which opened its office in Maputo in October.
Brazilian Minister Miguel Jorge, who was in Maputo last week heading up a business mission, said that after the factory was up and running, the technology and equipment needed for local production of the medication would be transferred.
Aas well as anti-retrovirals, the factory is also due to manufacture other generic drugs, including anti-malarials, antibiotics and tuberculosis medication.
According to Fiocruz – a health science and technology institute linked to the Brazilian government and which has carried out various cooperation projects in Mozambique – estimates that the first phase of the factory will cost around US$9 million, of which US$2 million will be provided by the Mozambican government.
This project has been on the table since 2003, at the time of a visit by the Brazilian President, Lula da Silva, to Mozambique, although the go-ahead was only given by the Brazilian Senate last week and the first phase of the project will be to package anti-retroviral medication. (macauhub)